Access to Artemisinin-Combination Therapy (ACT) and other Anti-Malarials: National Policy and Markets in Sierra Leone

• John H. Amuasi ,

  * E-mail: amuas001@umn.edu

  Affiliations University of Minnesota School of Public Health, PhD Program, Division of Health Policy and Management, Minneapolis, Minnesota, United States of America, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana

  ⨯
• Graciela Diap,

  Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

  ⨯
• Samuel Blay Nguah,

  Affiliation Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana

  ⨯
• Patrick Karikari,

  Affiliation Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana

  ⨯
• Isaac Boakye,

  Affiliation Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana

  ⨯
• Amara Jambai,

  Affiliation Ministry of Health and Sanitation, Freetown, Sierra Leone

  ⨯
• Wani Kumba Lahai,

  Affiliation Ministry of Health and Sanitation, Freetown, Sierra Leone

  ⨯
• Karly S. Louie,

  Affiliation Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Jean-Rene Kiechel

  Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

  ⨯